Showing posts with label psychosis. Show all posts
Showing posts with label psychosis. Show all posts

Wednesday, August 2, 2017

Could psychosis be confused with dementia

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

St. Michael's Hospital


DIAGNOSING DEMENTIA: In Alzheimer's, people with psychosis -- including delusions and hallucinations -- are five times more likely to be misdiagnosed with dementia with Lewy bodies. Find out why, and how to help your doctor arrive at the right diagnosis. 




People with Alzheimer's disease who experience psychosis -- including delusions and hallucinations -- are five times more likely to be misdiagnosed with dementia with Lewy bodies compared to patients who do not, new research suggests. 

Alzheimer's disease is a type of dementia characterized by protein deposits in the brain including twisted fibers found inside brain cells. Dementia with Lewy bodies is believed to be caused by the buildup of a different abnormal protein aggregate found in nerve cells in the brain. Effective treatments for these conditions are still under development, but will almost certainly be different, according to the authors. 

Researchers also found that Alzheimer's disease was misdiagnosed in 24 per cent of all cases, with false positive and false negative rates both being 12 per cent. Previous research suggested that the rate of misdiagnosis in Alzheimer's disease ranged from 12-23 per cent. 

The findings, published online in Alzheimer's & Dementia: Translational Research & Clinical Interventions, raise concern that there may be an under appreciation of how common psychotic symptoms are in Alzheimer's disease, said Dr. Corinne Fischer, director of the Memory Disorders Clinic at St. Michael's Hospital in Toronto and lead author of the study. 

"Psychosis can be a symptom of Alzheimer's disease, but it is a defining clinical feature in other types of dementia, including Parkinson's disease related dementia and dementia with Lewy bodies," she said. "Consequently, clinicians are more reluctant to diagnose a patient with Alzheimer's disease when they present with delusions or hallucinations." 

About 36 per cent of people with Alzheimer's are thought to have delusions and 18 per cent have hallucinations. Psychotic symptoms are significant in Alzheimer's patients because they have been shown to be associated with increased burden on caregivers, increased functional decline and more rapid progression of the disease. 

Researchers examined 961 people using data from the National Alzheimer's Coordinating Centre database, collected from 29 Alzheimer's disease centres in the United States between 2005 and 2012. They included participants who had been clinically diagnosed with Alzheimer's while they were alive, as well as those whose autopsies showed they the signature physical signs of Alzheimer's in their brains. 

Patients who experienced psychosis had a higher rate of false negative diagnosis and a lower rate of false positive diagnosis of Alzheimer's disease compared to those who did not. Whether patients experienced delusions, hallucinations, or a combination of both did not affect the rate of misdiagnosis, according to the authors. 

The Alzheimer's Society of Canada estimates there are 564,000 people living with dementia in Canada, and that number is expected to almost double over the next 15 years, thus reinforcing the relevance of the study's findings according to Winnie Qian, a Master's student in the Neuroscience Research Program at St. Michael's and an author on the study. 

"An advantage of our study is that we used the final clinical diagnosis after years of follow-up, so the rate of misdiagnosis we described is the rate under ideal conditions," she said. 

"This means that it should be considered a minimum. If you extrapolate that and apply it to the general population, the magnitude of the problem could be much greater." 

Dr. Fischer said when patients do not present with psychosis, clinicians should be more careful when considering alternative diagnoses to Alzheimer's disease. 

"Many dementia patients never receive a definitive clinical diagnosis while they're alive, so the hope is that by understanding what factors can lead to a misdiagnosis, we can be more accurate and provide patients with the best possible care," she said

    • Corinne E. Fischer, , Winnie Qian, Tom A. Schweizer, Zahinoor Ismail, Eric E. Smith, Colleen P. Millikin, David G. Munoz. Determining the impact of psychosis on rates of false-positive and false-negative diagnosis in Alzheimer's disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2017; 3 (3): 385 DOI: 10.1016/j.trci.2017.06.001


Wednesday, September 21, 2011

Atypical antipsychotic drugs may hasten dementia decline

Here is a great dementia resource for caregivers and healthcare professinals,

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two

Medscape Today
Deborah Brauser

Use of atypical antipsychotics to treat agitation or psychosis in patients with Alzheimer's disease (AD) may lead to severe cognitive impairment, according to new findings from the Clinical Antipsychotic Trials of Intervention Effectiveness–Alzheimer's Disease (CATIE-AD) study.

In the analysis, investigators found that patients with AD randomly assigned to olanzapine, quetiapine, or risperidone showed a significant decrement in neuropsychological functioning, as seen on several cognition measurements, compared with those receiving placebo.

"We found that the atypical antipsychotics used in this study were as a group associated with worsening cognitive function and that the magnitude of this impairment was, on average, the rough equivalent of 1 year's progression of illness," principal investigator of the CATIE-AD studies Lon S. Schneider, MD, professor of psychiatry, neurology, and gerontology at the University of California (USC) Keck School of Medicine in Los Angeles, told Medscape Medical News.

"It really comes down to the fact that the current medications aren't very effective in treating agitation, aggression, or psychosis in dementia. So maybe we should be trying to address these problems in different ways than merely prescribing the medications that have been licensed for treating patients with schizophrenia or major depression."

The study is published in the August issue of the American Journal of Psychiatry.

Efficacy Offset by Adverse Effects

"Delusions or hallucinations appear in 30% to 50% of patients with AD, and up to 70% demonstrate agitated or aggressive behaviors," report the researchers.

In a meta-analysis conducted the same year, Dr. Schneider's team found small effect sizes on symptom rating scales for aripiprazole and risperidone along with significant adverse events, including cerebrovascular events and worsening cognitive test scores, in older patients with AD.

"Any advantages of efficacy found for these drugs were offset in general by lack of tolerability and by adverse effects. So they should be used with a
Blog Flux Directory
alzheimersideas - whereIstand.com

Fitness is important in dementia prevention. Click below for more info